BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Historical Holders from Q1 2018 to Q1 2025

Symbol
BTAI on Nasdaq
CUSIP
09075P105
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
52.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
8.56M
Holdings value
$3.2M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
46
Number of buys
17
Number of sells
-24
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Oaktree Capital Group Holdings GP, LLC 5.2% $463K 2.72M Oaktree Capital Group Holdings GP, LLC Nov 25, 2024
Qatar Investment Authority 5.2% $463K 2.72M Qatar Investment Authority Nov 25, 2024

Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$32.9K 0
2024 Q4 8.56M $3.2M +$2.04M $0.37 46
2024 Q3 3.1M $1.89M -$7.94M $0.61 47
2024 Q2 9.74M $12.5M -$1.71M $1.28 71
2024 Q1 9.24M $26.1M -$488K $2.82 70
2023 Q4 9.35M $27.6M -$1.87M $2.95 69
2023 Q3 10.1M $25.6M -$27.9M $2.53 79
2023 Q2 17.6M $117M -$7.22M $6.66 82
2023 Q1 17.4M $324M +$70.4M $18.66 93
2022 Q4 13.4M $289M +$37.8M $21.48 79
2022 Q3 10.4M $122M -$12.2M $11.82 77
2022 Q2 11.2M $148M -$10.4M $13.20 86
2022 Q1 13.1M $274M -$16.4M $20.91 89
2021 Q4 13.7M $279M +$19.4M $20.33 86
2021 Q3 8.99M $273M -$29.4M $30.35 99
2021 Q2 13M $379M +$41.2M $29.06 106
2021 Q1 11M $475M -$55.2M $43.16 113
2020 Q4 12.2M $563M +$17.6M $46.20 110
2020 Q3 9.94M $431M +$75.9M $43.36 103
2020 Q2 8.12M $430M +$117M $53.01 100
2020 Q1 5.5M $123M +$37.5M $22.35 65
2019 Q4 4.33M $63M +$1.37M $14.61 41
2019 Q3 4.18M $29.4M +$8.27M $7.04 41
2019 Q2 2.93M $32M +$4.62M $10.95 33
2019 Q1 2.51M $24.9M +$932K $9.89 19
2018 Q4 2.42M $9.35M -$3.41M $3.85 11
2018 Q3 3.25M $25M -$3.83M $7.66 16
2018 Q2 3.72M $34.2M -$9.79M $9.20 18
2018 Q1 4.68M $47.8M +$47.8M $10.24 21